FATE vs QQQ
Fate Therapeutics Inc (FATE) versus Invesco QQQ Trust (QQQ) — a side-by-side from cached financials, not a winner call.
Fate Therapeutics Inc (FATE) is a biotechnology company listed on US.
Invesco QQQ Trust (QQQ) common stock listed on US.
Latest reported FATE revenue for 2026-06-30 was $3.4M. Net income was -$61.4M. FATE currently screens at market cap $331.0M.
QQQ does not have a complete income-statement cache yet.
FATE currently screens at market cap $331.0M. QQQ currently screens at market cap $0.
Not investment advice. Open the FATE and QQQ stock pages for the full models.
Not investment advice.